233 related articles for article (PubMed ID: 6366077)
1. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
[TBL] [Abstract][Full Text] [Related]
2. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
[TBL] [Abstract][Full Text] [Related]
3. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
Van de Verg L; Herrington DA; Murphy JR; Wasserman SS; Formal SB; Levine MM
Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813
[TBL] [Abstract][Full Text] [Related]
4. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
[TBL] [Abstract][Full Text] [Related]
5. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
Black RE; Levine MM; Clements ML; Losonsky G; Herrington D; Berman S; Formal SB
J Infect Dis; 1987 Jun; 155(6):1260-5. PubMed ID: 2437220
[TBL] [Abstract][Full Text] [Related]
6. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains].
Chen QY; Jiang LJ; Kong DC; Wang BR
Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424
[No Abstract] [Full Text] [Related]
7. Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen.
Seid RC; Kopecko DJ; Sadoff JC; Schneider H; Baron LS; Formal SB
J Biol Chem; 1984 Jul; 259(14):9028-34. PubMed ID: 6378905
[TBL] [Abstract][Full Text] [Related]
8. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.
Formal SB; Baron LS; Kopecko DJ; Washington O; Powell C; Life CA
Infect Immun; 1981 Dec; 34(3):746-50. PubMed ID: 6174449
[TBL] [Abstract][Full Text] [Related]
9. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
[No Abstract] [Full Text] [Related]
10. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
Herrington DA; Van de Verg L; Formal SB; Hale TL; Tall BD; Cryz SJ; Tramont EC; Levine MM
Vaccine; 1990 Aug; 8(4):353-7. PubMed ID: 2204243
[TBL] [Abstract][Full Text] [Related]
11. Oral vaccination against enteric bacterial infections: an overview.
Germanier R
Infection; 1985; 13 Suppl 2():S206-10. PubMed ID: 3902655
[TBL] [Abstract][Full Text] [Related]
12. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain.
Hartman AB; Ruiz MM; Schultz CL
J Clin Microbiol; 1991 Jan; 29(1):27-32. PubMed ID: 1993762
[TBL] [Abstract][Full Text] [Related]
15. Cell wall structures which may be important for successful immunization with Salmonella-Shigella hybrid vaccines.
Schultz CL; Kaufman B; Hamilton D; Hartman A; Ruiz M; Powell C; Berman S
Vaccine; 1990 Apr; 8(2):115-20. PubMed ID: 2159678
[TBL] [Abstract][Full Text] [Related]
16. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use.
Joó I
Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974
[TBL] [Abstract][Full Text] [Related]
17. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.
Cryz SJ; Vanprapar N; Thisyakorn U; Olanratmanee T; Losonsky G; Levine MM; Chearskul S
Infect Immun; 1993 Mar; 61(3):1149-51. PubMed ID: 8432597
[TBL] [Abstract][Full Text] [Related]
19. Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.
Keren DF; Collins HH; Baron LS; Kopecko DJ; Formal SB
Infect Immun; 1982 Jul; 37(1):387-9. PubMed ID: 7049953
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
